Concepedia

Author

Fred Racine

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

F. Racine, Fred Racine

20

Publications

1.1K

Citations

13

H-Index

44

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Scynexis (United States)MSD (Spain)United States Military Academy
FR

About

Fred Racine is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

861

2

Natural Sciences

2

2

168

3

Biochemistry

2

2

65

4

Engineering

1

1

380

5

Health Sciences

1

1

47

Fred Racine

×

13

Publications

1.1K

Citations

13

H-Index

YearCitations

Discovery of platencin, a dual FabF and FabH inhibitor with <i>in vivo</i> antibiotic properties

Jun Wang, Srinivas Kodali, Sang Ho Lee,

Proceedings of the National Academy of Sciences

2007

380

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

Peter Orth, Li Xiao, Lorraine D. Hernandez,

Journal of Biological Chemistry

2014

135

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Katherine Young, Ronald E. Painter, Susan L. Raghoobar,

BMC Microbiology

2019

120

Caspofungin Susceptibility in <i>Aspergillus</i> and Non- <i>Aspergillus</i> Molds: Inhibition of Glucan Synthase and Reduction of β- <scp>d</scp> -1,3 Glucan Levels in Culture

Jennifer Nielsen Kahn, Ming‐Jo Hsu, Fred Racine,

Antimicrobial Agents and Chemotherapy

2006

61

Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model

Jin Wu, Fred Racine, Michael K. Wismer,

Antimicrobial Agents and Chemotherapy

2018

61

Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted by <i>In Vitro</i> Neutralization and Epitope Modeling

Lorraine D. Hernandez, Fred Racine, Li Xiao,

Antimicrobial Agents and Chemotherapy

2014

53

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

James M. Apgar, Robert R. Wilkening, Dann L. Parker,

Bioorganic & Medicinal Chemistry Letters

2020

48

A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam

Pratik Bhagunde, Zufei Zhang, Fred Racine,

International Journal of Infectious Diseases

2019

47

Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection

Z. Zhang, X. Chen, Lorraine D. Hernandez,

Infection and Immunity

2014

44

Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab

Lorraine D. Hernandez, Heather K. Kroh, Edward J. Hsieh,

Journal of Molecular Biology

2017

42

Page 1